QuantX Biosciences Funding: $130M Raised, Series B (2026)
QuantX Biosciences is based in Princeton, NJ. It has raised $130M in total funding. Latest round: Series B. Backed by LAV, Sanofi Ventures, Hongshan.
QuantX Biosciences funding overview
QuantX Biosciences is based in Princeton, NJ. QuantX Biosciences has raised $130M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in February 2026. The round record for QuantX Biosciences runs through 2026; nothing later has been disclosed. Investors on record include LAV, Sanofi Ventures, Hongshan, OrbiMed, Creacion Ventures. 5 distinct backers are named across the disclosed rounds.
QuantX Biosciences has raised $130M in total disclosed funding across the rounds on record.
Who has invested in QuantX Biosciences?
LAV, Sanofi Ventures, Hongshan, OrbiMed, Creacion Ventures are named among the investors backing QuantX Biosciences.
What was the latest QuantX Biosciences funding round?
The most recent disclosed round is a Series B, announced in February 2026.
Where is QuantX Biosciences based?
QuantX Biosciences is based in Princeton, NJ.
When did QuantX Biosciences last raise?
The last disclosed QuantX Biosciences round closed in February 2026 at Series B.
Totals shown for QuantX Biosciences aggregate every disclosed round on file. To see how that compares, browse the companies in Princeton and the investors behind them below.
